Elranatamab
ATC L01FX32 · 10 markets · 20 records
AU 5 records · 5 strengths
- 76 mg/1.9 mLinjectionElrexfio
- 44 mg/1.1 mLinjectionElrexfio
- 76 mginjectionELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial
- 44 mginjectionELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 3 records · 2 strengths
GB 2 records · 2 strengths
- 76 mg/1.9 mLinjectionElrexfio 44mg/1.1ml solution for injection vials
- 44 mg/1.1 mLinjectionElrexfio 44mg/1.1ml solution for injection vials
CA 2 records · 1 strengths
- 40 mg/1 mLliquidElrexfio
SG 2 records · 2 strengths
- 76 mg/1.9 mLinjectionELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML
- 44 mg/1.1 mLinjectionELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 1 records · 1 strengths
- 40 mg/1 mLinjectionElrexfio
TW 1 records · 1 strengths
- 40 mginjectionELREXFIO 40mg/mL solution for癌適求注射液40毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 40 mg/1 mLinjectionELREXFIO 40 mg/mL, solution injectable
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 76 mg/1.9 mL injection | Elrexfio | Elrexfio 44mg/1.1ml solution for injection vials | Elrexfio | ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML | ||||||
| 44 mg/1.1 mL injection | Elrexfio | Elrexfio 44mg/1.1ml solution for injection vials | Elrexfio | ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML | ||||||
| 40 mg/1 mL injection | Elrexfio | ELREXFIO 40 mg/mL, solution injectable | ||||||||
| 40 mg injection | ELREXFIO 40mg/mL solution for 癌適求注射液40毫克/毫升 | |||||||||
| 40 mg/1 mL liquid | Elrexfio | |||||||||
| 76 mg injection | ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial | |||||||||
| 44 mg injection | ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial | |||||||||
unknown | Elrexfio | ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML | Elrexfio |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · ES · TW · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · ES · TW · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · ES · TW · FR 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 CA · ES · TW · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.